Profound Medical Corp
TSX:PRN

Watchlist Manager
Profound Medical Corp Logo
Profound Medical Corp
TSX:PRN
Watchlist
Price: 8.795 CAD 9.39% Market Closed
Market Cap: CA$319.2m

Wall Street
Price Targets

PRN Price Targets Summary
Profound Medical Corp

Wall Street analysts forecast PRN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRN is 11.73 CAD with a low forecast of 11.615 CAD and a high forecast of 12.075 CAD.

Lowest
Price Target
11.615 CAD
32% Upside
Average
Price Target
11.73 CAD
33% Upside
Highest
Price Target
12.075 CAD
37% Upside
Profound Medical Corp Competitors:
Price Targets

Revenue
Forecast

N/A
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
70% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate of Profound Medical Corp's revenue for the next 3 years is 70%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRN's stock price target?
Price Target
11.73 CAD

According to Wall Street analysts, the average 1-year price target for PRN is 11.73 CAD with a low forecast of 11.615 CAD and a high forecast of 12.075 CAD.

What is Profound Medical Corp's Revenue forecast?
Projected CAGR
70%

The compound annual growth rate of Profound Medical Corp's revenue for the next 3 years is 70%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett